EvoEndo, Inc., a Denver CO-based preclinical medical device company which specializes in developing systems for unsedated Transnasal Endoscopy (TNE), raised $10.1M in funding.
The Backers were undisclosed.
The company intends to use the funds to advance its technology.
Co-founded in 2017 by Dr. Joel Friedlander and led by Heather Underwood, Chief Executive Officer, EvoEndo is developing technology to help physicians diagnose, treat, and monitor conditions for a variety of gastrointestinal disorders. The system combines sterile, single-use, flexible endoscopes with VR-based patient distraction to allow the procedure to be performed safely in children and adults without anesthesia or sedation. The company is led by Heather Underwood, PhD, an experienced medical device and technology entrepreneur, and alumna of the Stanford University Biodesign Program.
The system is currently pending U.S. FDA 510 (k) clearance and is not available for sale in the United States.